Effects of the sodium‐glucose cotransporter 2 (SGLT2) inhibitor velagliflozin,a new drug with therapeutic potential to treat diabetes in cats

Sodium‐glucose cotransporter 2 (SGLT2) inhibitors are used in the treatment of human diabetics. They increase glucose excretion and correct hyperglycemia. We examined the investigational SGLT2 inhibitor velagliflozin in two groups of six neutered adult obese cats (equal gender distribution). Placebo (Pl) or drug (D; 1 mg/kg) was administered for 35 days. Routine blood examinations, fructosamine, beta‐hydroxybutyrate (BHB), nonesterified fatty acids (NEFA), glucagon, adiponectin, and leptin were measured before and after treatment, also water intake, and urinary electrolytes, glucose, and volume. Indirect calorimetry, an intravenous glucose tolerance test (IVGTT; 0.8 g/kg) and insulin tolerance test (IVITT) were conducted. All cats tolerated treatment well. Significant changes with D included a decrease in the respiratory exchange ratio, an increase in cholesterol, a small increase in albumin, and a rise in BHB and NEFA. Glucose clearance was unaltered, although less insulin was secreted during the IVGTT (p = .056) suggesting improved insulin sensitivity. IVITT was unchanged. Treatment did not affect glucagon, leptin, or adiponectin. Water intake, urine output, urinary glucose excretion, and the glucose/creatinine ratio but not urinary electrolytes were significantly higher post‐D. We conclude that velagliflozin is a promising drug, which increases urinary glucose excretion in cats and could thereby be beneficial for the treatment of hyperglycemia.     

Food intake and energy expenditure in growing cats with and without a predisposition to overweight

Overweight and obesity are multifactorial diseases caused by an imbalance in energy metabolism. An underlying genetic predisposition is often a factor in these conditions. In the cat breeding family of the Institute of Animal Nutrition at the Vetsuisse Faculty, University of Zurich, a segregating overweight phenotype with a genetic contribution was observed. From this breeding family, 26 kittens were followed from birth up to 8 months of age. During this time, food intake was measured using an automatic feeding station, and energy expenditure was investigated using indirect calorimetry at the ages of 4 and 6 months. Dual‐energy X‐ray absorptiometry (DEXA) was performed and blood glucose, leptin and insulin were measured at the ages of 4, 6 and 8 months. The kittens were also weighed daily for the first 2 weeks of life, every second day until weaning and once per week until 8 months of age. The body condition score (BCS) was evaluated monthly between 2 and 8 months of age. The main finding of this study is that a predisposition to overweight is connected to a higher food intake early in life, with no significant alterations in energy expenditure. The leptin blood levels were related to body fat percentage, and insulin sensitivity did not seem to be affected.     

兔出血症-巴氏杆菌病铝胶二联灭活苗的研制

筛选了具有良好免疫原性的兔瘟强毒株GMH881和兔巴氏杆菌C51-17株,研制出了兔出血症-巴氏杆菌二联铝胶灭活苗,对疫苗进行了免疫剂量、免疫产生期、兔出血症抗体测定、免疫保护期、保存期等试验;确定出二联铝胶苗免疫剂量1.0 mL;二联铝胶苗在免疫后7 d对兔病毒性出血症强毒的保护率达到100%,二联苗免疫后10～14 d对兔巴氏杆菌的保护率均达到75%以上;二联铝胶苗的兔病毒出血症抗体测定结果表明：二联铝胶苗免疫家兔后7 d,HI抗体均可达25.0,15 d明显上升,二联苗HI效价60～90 d达到最高峰,最高可达210,二联苗在120～180 d仍可维持在27.0～29.5水平。二联铝胶苗分别在免疫后4个月、6个月用兔出血症强毒攻击均产生100%保护,在6个月用2个MLD的兔巴氏杆菌攻击保护率可达70%以上,二联铝胶苗4～8℃条件下保护期暂定为1年,25℃条件下暂定为半年。     

植物免疫诱抗剂的作用机理和应用研究进展

植物免疫诱抗剂除了能诱导植物免疫反应以使植物获得或提高对病菌的抗性外,也可以激发植物体内代谢调控过程,促进植物生长,增加作物产量。植物免疫诱抗剂可以诱导植物产生系统获得抗性以使植物对病原菌产生广泛、长期的抗性。本综述全面、系统地介绍了植物免疫诱抗剂的种类及其目前在生产、病害防治上的应用状况,阐述了其作用机理,并展望了植物免疫诱抗剂的应用前景。通过对植物免疫诱抗剂发展历史和应用现状的分析,旨在为植物免疫诱抗剂未来的开发和应用提供一定的理论和实践依据。     

加强生长育肥猪的饲养管理减少疾病的发生

在整个养猪生产中,育肥是养猪的最后一个生产环节,是检测猪种选择是否正确,营养饲料是否适合,饲养技术是否过硬,疫病防控是否完善的关键,不仅关系到市场供应,而且对猪场经济效益有着重要影响,也是发展养猪生产的最终目的。     

基于相对熵排序的建筑工程项目投标决策

投标决策是施工企业面对的重要问题．在建筑工程项目投标问题上，先建立风险指标体系，再结合层次分析法和信息熵法求得风险指标的综合权重，然后借助相对熵排序法，对各个方案进行综合评价，得到有效反映各方案差异的评价模型，通过对比可知此法可行有效，且灵敏度高．     

枯草芽孢杆菌在番茄病害防治上的应用与研究进展

综述了枯草芽孢杆菌在防治植物病害中的生防机制,包括竞争作用、拮抗作用、溶菌作用、诱导植物产生抗性和促进植物生长5个方面,介绍了枯草芽孢杆菌在6种番茄病害即灰霉病、青枯病、早疫病、立枯病、枯萎病、根腐病防治中的应用,并对其应用中存在的主要问题进行了总结、前景进行了展望。     

肉牛源细极链格孢菌的分离鉴定

为鉴定肉牛皮肤病病原及其致病性并筛选其敏感药物,本研究取患皮肤病肉牛病变部位皮屑、毛发和痂皮进行病原菌的分离,并对分离菌株进行了形态学鉴定、ITS序列分析、小鼠致病性试验和药敏试验。结果显示分离到1株形态特征与细极链格孢菌极其相似的菌株(PY2-1-2);经PCR扩增、测序和BLAST序列比对,结果显示分离株(PY2-1-2)的ITS基因序列与细极链格孢菌(MG975630.1)的ITS基因序列的相似性为99%,分离株PY2-1-2的ITS基因序列长度为543 bp,该片段包括ITS1、5.8S rDNA和ITS2的全部基因序列以及18S rDNA和28S rDNA的部分基因序列,提交GenBank(MH656780.1)。根据形态学结合ITS基因序列分析结果确定该分离株为细极链格孢菌。小鼠致病性试验结果显示该菌对小鼠有致病性。药敏试验结果显示:该菌对灰黄霉素、氟康唑、伊曲康唑、酮康唑的最小抑菌浓度(MIC)值分别为0.5μg/mL、4μg/mL、1μg/mL、1μg/mL。本研究为今后进一步探究细极链格孢菌引起的皮肤病诊治提供科学有效的参考。     

基于响应面法和NSGA-II算法的麦弗逊悬架优化

应用响应面法和经过改进的非支配排序遗传算法(NSGA-II)进行悬架结构参数优化.在ADAMS/Insight软件中进行设计参数的灵敏度分析，针对灵敏度较大的设计参数，建立车轮定位参数在车轮跳动过程中最大变化量的2阶响应面近似数学模型对该模型进行稳定性分析，并且应用加入精英保持策略和去除重复个体算法的NSGA-II优化算法对多目标响应面模型进行优化求解.优化结果表明该方法具有较高的精确性与有效性.